v3.20.4
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]      
Revenue $ 1,092,673 $ 742,555 $ 595,409
Cost of revenue 352,547 242,373 165,401
Gross profit 740,126 500,182 430,008
Operating expenses:      
Sales and marketing 683,701 450,120 461,762
Research and development 560,660 305,563 285,451
General and administrative 669,444 320,943 306,235
Total operating expenses 1,913,805 1,076,626 1,053,448
Loss from operations (1,173,679) (576,444) (623,440)
Interest income 4,680 15,090 10,500
Interest expense (14,139) (3,061) (3,440)
Change in fair value of warrants 811 (3) 48,093
Other income (expense), net 3,300 (2,853) (2,638)
Loss before provision (benefit) for income taxes (1,179,027) (567,271) (570,925)
Provision (benefit) for income taxes (12,636) 12,375 9,102
Net loss (1,166,391) (579,646) (580,027)
Net loss attributable to common stockholders $ (1,166,391) $ (588,127) $ (598,125)
Net loss per share attributable to common stockholders, basic $ (1.19) $ (1.02) $ (1.11)
Net loss per share attributable to common stockholders, diluted $ (1.20) $ (1.02) $ (1.17)
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, basic 977,721,736 576,958,560 537,280,394
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, diluted 979,330,067 576,958,560 544,014,393